Author Archive: Tracy Cooley

Tracy Cooley

Tracy serves as the Director of Events Communications and handles all communications for BIO’s events and emerging company policy issues. She loves blogging and podcasting on all things biotech and believes in the great potential of the industry, looking for every opportunity to spread the message far and wide. Nearly everyone in her family is a golfer, and as such, she has what many people have called a “natural” swing. Sometimes she even hits the ball. Tracy just finished her ninth marathon, and has nearly mastered the skill of one-foot-in-front-of-the-other (usually, sometimes the laces get in the way). The joy of her life is her five-year-old daughter Josephine.

Latest Posts

CFO Magazine: On the IPO On-Ramp

lab_tech

CFO Magazine highlighted the impact of the Jumpstart Our Business Startups (JOBS) Act on smaller companies aiming to obtain access to capital and the benefits of the JOBS Act by highlighting case studies from companies that went public using it. “Nearly everyone agrees that the JOBS Act has significantly affected the way IPOs are done,” writes Edward Teach. Teach talked to five companies to discuss their experiences, and not surprisingly, ‘all had strong opinions about Read More >

Business and Investments, Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

CNN: Sandy’s Story

scientist-eyedropper

CNN launched a new series profiling Sandy Halperin, a dentist and Harvard assistant professor, to raise awareness for the devastating impact of Alzheimer’s disease on a patient and his family. Producer Stephanie Smith describes Sandy’s Story as ‘an unprecedented look at the cruel journey of a vibrant, once healthy man as he gradually loses his memory.’ Halperin was diagnosed with early stage Alzheimer’s disease at age 60. The in-depth package explores the day-to-day reality of Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Ebola Outbreak Highlights Value of Cures

shutterstock_26191726

Forbes recently published an op-ed comparing the outbreak and spread of the Ebola virus with the value of cures to prevent disease and save lives. The author – Merrill Matthews – is a resident scholar with the Institute for Policy Innovation in Dallas, Texas. Matthews asserts that drug companies are in the business of discovering cures for deadly and debilitating diseases, and need support for expediting research and development by cutting through red tape and Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

Jack the Ripper Mystery May Be Solved through DNA Testing

JacktheRipper1888

Author Russell Edwards and Jari Louhelainen, a molecular biology professor at Liverpool John Moores University claim to have solved the 126-year-old mystery surrounding the identity of Jack the Ripper, which is the pseudonym of a serial killer who murdered at least five women in East London in the late 1800s. Edwards bought a shawl that was found near the body of one of the victims – Catherine Eddowes – at an auction. He then worked Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

Patients Suffering from Gaucher’s Disease Deserve Better

scientist-eyedropper

Gaucher Disease is one of the over 6,000 rare diseases that affect patients worldwide, representing a frontier of unmet medical need [NCATS, NIH]. The challenges for drug development generally—long and costly research and development timelines—are exacerbated by the inherently small patient populations affected by rare diseases. These patients can be difficult to identify and geographically dispersed and their clinical presentation can be quite disparate, complicating the design and recruitment for clinical trials used to determine Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,